Kither Biotech
2011
FOUNDED
PRIVATE
STATUS
Seed
LATEST DEAL TYPE
$6.32M
LATEST DEAL AMOUNT
9
INVESTORS
Description
Developer of anticancer and anti inflammation compounds intended to treat chronic inflammatory diseases. The company has developed drug for the treatment of cystic fibrosis, a disease that predominantly affects the lungs and is inline to create medication for the cure of chronic obstructive pulmonary diseases and allergic asthma, providing patients with a treatment for their uncurable respiratory diseases.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
- Via Nizza 52
- Turin
- Italy
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Kither Biotech’s full profile, request a free trial.
Kither Biotech Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 15-Jul-2019 | $6.32M | 00.000 | Completed | Pre-Clinical Trials | |
| 1. Accelerator/Incubator | Completed | Startup |
Kither Biotech Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Ace Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| B-Engine | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Claris Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Club degli investitori | Angel Group | Minority | 000 0000 | 000000 0 | ||
| Elysian Capital | PE/Buyout | Minority | 000 0000 | 000000 0 |
Kither Biotech Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Marco Malisani | Co-Founder & Chief Executive Officer | ||
| Emilio Hirsch | Co-Founder & Chief Scientific Officer | ||
| Alberto Bardelli | Executive | ||
| Gian Tron | Executive |